An early feasibility study for neurological devices: The ARCTRAN study.
Saved in:
| Title: | An early feasibility study for neurological devices: The ARCTRAN study. |
|---|---|
| Authors: | Bove, Francesco (AUTHOR), Di Lazzaro, Giulia (AUTHOR), Petracca, Martina (AUTHOR), Lo Monaco, Maria Rita (AUTHOR), Ricciardi, Diego (AUTHOR), Di Caro, Francesca (AUTHOR), Fragapane, Serena (AUTHOR), Giovannini, Silvia (AUTHOR), Iacovelli, Chiara (AUTHOR), Castelli, Letizia (AUTHOR), Bianco, Assunta (AUTHOR), Scala, Irene (AUTHOR), Broccolini, Aldobrando (AUTHOR), Caliandro, Pietro (AUTHOR), Le Pera, Domenica (AUTHOR), Furno, Carmen (AUTHOR), Arcuri, Giovanni (AUTHOR), Fares, Guerino Massimo Oscar (AUTHOR), Spandonaro, Federico (AUTHOR), Polistena, Barbara (AUTHOR) |
| Source: | Neurological Sciences. Oct2025, Vol. 46 Issue 10, p5221-5233. 13p. |
| Subjects: | Home rehabilitation, Parkinson's disease, Medical sciences, Neurological disorders, Stroke |
| Abstract: | Introduction: An Early Feasibility Study (EFS) is an exploratory clinical investigation of a device to optimize its design through iterative feedback loops during early clinical experience. The ARCTRAN study is an EFS aimed at analyzing efficacy, safety and adherence to the home-rehabilitation device-based (ARC Intellicare) program compared to a paper-based exercise protocol in patients with Parkinson's disease (PD), Multiple Sclerosis (MS) and stroke. Materials and Methods: At baseline (T0), patients of each group were randomly divided into two arms, with a 1:1 ratio: an 'interventional' group received ARC Intellicare and a 'control' group received a paper-based rehabilitation protocol, both consisting of three 60-minute sessions/week for 8 weeks. Each patient was evaluated by means of clinical scales, gait analysis and stabilometry at baseline (T0) and after the rehabilitation (T2). Results: All patients (n = 90, 30 per group) showed a significant improvement in clinical scales between T0 and T2. Stroke patients showed a bigger gait improvement in the ARC Intellicare arm, measured both by clinical scales (Tinetti gait p = 0.01) and gait analysis parameters. In PD group, only gait analysis parameters recorded a significant improvement in the active arm. Discussion: We demonstrate the safety of ARC Intellicare for home-based rehabilitation in patients with chronic neurological conditions, with high adherence levels. Moreover, in stroke group, it produced more significant improvements of gait compared to paper-based protocol. In the global scenario of the EFS projects promoted by the Italian Ministry of Health, this study is a starting point to conduct this type of studies in Italy. [ABSTRACT FROM AUTHOR] |
| Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
